Aqgen Pharma Llp - Company Profile

It is a paper limited liability partnership based in Sangareddy, Telangana, India, established in 2023.
2023 Sangareddy, Telangana, India Active
Last Updated:
Access Report
About Aqgen Pharma Llp

Aqgen Pharma Llp, a active limited liability partnership, was established on 21 August 2023 in Sangareddy, Telangana, India. Engaging in manufacturing within the paper sector, it holds LLPIN: ACC-5526. Registered under ROC Roc Hyderabad. It has total obligation of contribution of ₹0.10 M.

Formerly known as Aqgen Biologics Llp. Its leadership includes Divyabhishek Reddy Kambham (Designated Partner), Dheeraj Reddy Kambam (Designated Partner), Nikitha Reddy Penubaka (Designated Partner). Past directors included Yogabhishek Kambam. Its latest date of accounts and solvency statement 31 March 2024. It is based at Survey Nos.304/Aa2/2 And 304/Aa2/3, Indrakaran Village,, Kandi Mandal,, Sangareddy, Telangana, 502329.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    ACC-5526

  • Incorporation Date

    21 August 2023

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 2 Year, 5 Months
  • Last Filing with ROC 31 Mar 2024
Company report

Aqgen Pharma Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aqgen Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Aqgen Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Divyabhishek Reddy Kambham Designated Partner 21 Aug 2023 Current
Dheeraj Reddy Kambam Designated Partner 21 Aug 2023 Current
Nikitha Reddy Penubaka Designated Partner 21 Aug 2023 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Designated Partner 19 Feb 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aqgen Pharma Llp.

Enhance accessibility to Aqgen Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Aqgen Pharma Llp revenue growth over time
Aqgen Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aqgen Pharma Llp?

Unlock access to Aqgen Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Aqgen Pharma Llp?

Unlock and access historical data on people associated with Aqgen Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aqgen Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aqgen Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aqgen Pharma Llp
Recent Activity within the Organization
  • Annual General Meeting

    Aqgen Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was recorded as a recent event.

  • Statement of Assets & Liabilities

    Progress on Aqgen Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.

  • Director Appointment

    Progress on Divyabhishek Reddy Kambham was appointed as a Designated Partner was appointed as a Designated Partner on 21 Aug 2023 & has been associated with this company since 2 years 5 months . was documented.

  • Director Appointment

    The activity Dheeraj Reddy Kambam was appointed as a Designated Partner was appointed as a Designated Partner on 21 Aug 2023 & has been associated with this company since 2 years 5 months . was completed.

  • Director Appointment

    Nikitha Reddy Penubaka was appointed as a Designated Partner was appointed as a Designated Partner on 21 Aug 2023 & has been associated with this company since 2 years 5 months . was recorded as a recent event.

  • LLP Incorporation

    Aqgen Pharma Llp was registered on 21 Aug 2023 with Roc Hyderabad & aged 2 years 5 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Aqgen Pharma Llp?

The LLPIN of Aqgen Pharma Llp is ACC-5526.

Where is Aqgen Pharma Llp headquartered?

Aqgen Pharma Llp is headquartered at Survey Nos.304/Aa2/2 And 304/Aa2/3, Indrakaran Village,, Kandi Mandal,, Sangareddy, Telangana, 502329.

When was Aqgen Pharma Llp incorporated?

Aqgen Pharma Llp was incorporated on 21 August 2023.

Who are the current directors of Aqgen Pharma Llp?

The current directors of Aqgen Pharma Llp are

What is the primary industry of Aqgen Pharma Llp?

The primary industry of Aqgen Pharma Llp is Paper.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available